EW
32
3
ADP
65
-3
NWSA
62
-7
TMO
42
-6
FTI
71
-7
EA
60
-5
AME
74
-4
TROW
47
-6
VMC
53
-4
ORCL
63
-4
BSX
64
-3
BEN
50
9
RCL
83
-2
SIG
44
-3
LRCX
37
-9
ALL
50
2
CMI
64
-3
DTE
43
5
PSA
56
3
AAPL
40
-6
EW
32
3
ADP
65
-3
NWSA
62
-7
TMO
42
-6
FTI
71
-7
EA
60
-5
AME
74
-4
TROW
47
-6
VMC
53
-4
ORCL
63
-4
BSX
64
-3
BEN
50
9
RCL
83
-2
SIG
44
-3
LRCX
37
-9
ALL
50
2
CMI
64
-3
DTE
43
5
PSA
56
3
AAPL
40
-6
Financhill
Back

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
40

FFC
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Last Price:
15.77
Seasonality Move:
3.11%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
40
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated (FFC) is a Sell

Is Flaherty & Crumrine Preferred and Income Securities Fund Incorporated a Buy, Sell or Hold?

  • The current Flaherty & Crumrine Preferred and Income Securities Fund Incorporated [FFC] share price is $15.75. The Score for FFC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • FFC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FFC Stock Price Chart

What is Flaherty & Crumrine Preferred and Income Securities Fund Incorporated's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FFC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.65 Sell
Chaikin Money Flow: 97238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.86 - 16.28) Sell
Bollinger Bands (100): (14.97 - 16.33) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FFC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.95 Sell
20-day SMA: 15.99 Sell
50-day SMA: 16.24 Sell
200-day SMA: 15.05 Buy
8-day EMA: 15.89 Sell
20-day EMA: 16 Sell
50-day EMA: 16 Sell
200-day EMA: 15.23 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated Earnings Growth & FFC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):